Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter

Completed · Phase 3 · Has a placebo group

Conditions studied: Atrial Flutter, Atrial Fibrillation

In brief

The purpose of this study is to demonstrate the effectiveness of RSD1235 compared with placebo, in the conversion of atrial fibrillation or atrial flutter to sinus rhythm.

Key facts

Study ID

NCT00115791

Run by

Astellas Pharma Inc

People needed

276

Starts

2004-06-01

Expected to finish

2005-06-01

Last updated by the study team

2008-04-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Atrial flutter or atrial fibrillation that has been sustained for greater than 3 hours and up to 45 days

You may not qualify if…

• Myocardial infarction, acute coronary syndrome or cardiac surgery within 30 days prior to randomization

Where it is running

• Investigative Site — Huntsville, Alabama, United States
• Investigative Site — Gainesville, Florida, United States
• Investigative Site — Orlando, Florida, United States
• Investigative Site — Port Charlotte, Florida, United States
• Investigative Site — Indianapolis, Indiana, United States
• Investigative Site — Shreveport, Louisiana, United States
• Investigative Site — Baltimore, Maryland, United States
• Investigative Site — Lansing, Michigan, United States
• Investigative Site — Petoskey, Michigan, United States
• Investigative Site — Saint Paul, Minnesota, United States
• Investigative Site — Tupelo, Mississippi, United States
• Investigative Site — Holmdel, New Jersey, United States
• Investigative Site — Cincinnati, Ohio, United States
• Investigative Site — Amarillo, Texas, United States
• Investigative Site — Houston, Texas, United States
• Investigative Site — Richmond, Virginia, United States
• Investigative Site — Tacoma, Washington, United States
• Investigative Site — Marshfield, Wisconsin, United States
• Investigative Site — Buenos Aires, Argentina
• Investigative Site — Buenos Aires, Argentina
• Investigative Site — Buenos Aires, Argentina
• Investigative Site — Buenos Aires, Argentina
• Investigative Site — Mendoza, Argentina
• Investigative Site — Calgary, Alberta, Canada
• Investigative Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.